play

To reshape

Protein therapeutics discovery with
next-generation AI

Helixon is developing technology platforms that transform the discovery of protein therapeutics.

About
We aim to design

Novel antibodies

to target antigen epitopes precisely. By integrating deep learning, structural biology and high-throughput techniques, our platform enables more efficient discovery, and with a higher successful rate, compared to traditional methods.
Our integrated platform conjoins

Deep learning and
high-throughput biology

designing antibody sequences at massive scale, predicting their properties,
validating via experiments, and self-improving iteratively.

We balance the tradeoff between exploration and exploitation and
search the sequence landscape, aiming for more precise epitope targeting and
better developability after each iterative design cycle.

合作生态

Deep learning models of antibody-antigen interaction landscape

We train deep learning models to predict binding between antibodies and antigens. With ever-growing structural a=nd functional data, our models become more precise and detailed.

合作生态

Deep learning models of antibody-antigen interaction landscape

We train deep learning models to predict binding between antibodies and antigens. With ever-growing structural a=nd functional data, our models become more precise and detailed.

News

AI drug discovery platform officially opened for use

We could generate novel protein therapeutics using new computational tools, without having to discover them through trial and error

AI drug discovery platform

We could generate novel protein therapeutics using new computational tools, without having to discover them through trial and error
Careers

Working
Together

to out-evolve nature

We are building a team of passionate scientists and engineers to drive scientific advances and technology innovations for bringing better therapies and improving human health.